US FDA to Monitor Clinical Trial Data in Real Time
Digest more
The FDA has launched a pilot program allowing real-time review of clinical trial data, with AstraZeneca and Amgen as the first participants. The initiative aims to speed up drug development by ...
On December 15, 2025, the US Food and Drug Administration (FDA) issued a press release announcing that FDA eliminated a major barrier to the use of real-world evidence (RWE) in medical device ...
FDA granted rapid expanded access for daraxonrasib in previously treated metastatic PDAC, reflecting urgency and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results